These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1329 related articles for article (PubMed ID: 17200597)

  • 21. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?
    Cutts TF; Luo J; Starkebaum W; Rashed H; Abell TL
    Neurogastroenterol Motil; 2005 Feb; 17(1):35-43. PubMed ID: 15670262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in use and costs of primary health and social services in mental health or drinking problems.
    Forma L; Jarvala T; Ahonen J; Vitikainen K; Rissanen P
    J Ment Health Policy Econ; 2009 Jun; 12(2):79-86. PubMed ID: 19567933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution between Formal and Informal Care for Persons with Severe Mental Illness and Substance Use Disorders.
    Clark RE; Xie H; Adachi-Mejia AM; Sengupta A
    J Ment Health Policy Econ; 2001 Sep; 4(3):123-132. PubMed ID: 11967472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost-effectiveness and cost-utility study of lung transplantation.
    Vasiliadis HM; Collet JP; Penrod JR; Ferraro P; Poirier C
    J Heart Lung Transplant; 2005 Sep; 24(9):1275-83. PubMed ID: 16143245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAFE Homes: is it worth the cost? An evaluation of a group home permanency planning program for children who first enter out-of-home care.
    DeSena AD; Murphy RA; Douglas-Palumberi H; Blau G; Kelly B; Horwitz SM; Kaufman J
    Child Abuse Negl; 2005 Jun; 29(6):627-43. PubMed ID: 15979706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline recommendations for treatment of schizophrenia: the impact of managed care.
    Dickey B; Normand SL; Hermann RC; Eisen SV; Cortes DE; Cleary PD; Ware N
    Arch Gen Psychiatry; 2003 Apr; 60(4):340-8. PubMed ID: 12695310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study.
    Hong J; Windmeijer F; Novick D; Haro JM; Brown J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):835-41. PubMed ID: 19351551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic effect of a tertiary hospital-based heart failure program.
    Gregory D; DeNofrio D; Konstam MA
    J Am Coll Cardiol; 2005 Aug; 46(4):660-6. PubMed ID: 16098432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.